HomeCompareETHOF vs MRK

ETHOF vs MRK: Dividend Comparison 2026

ETHOF yields 1594.90% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ETHOF wins by $1228719512.52M in total portfolio value
10 years
ETHOF
ETHOF
● Live price
1594.90%
Share price
$0.13
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1228719512.57M
Annual income
$1,093,808,718,533,524.60
Full ETHOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ETHOF vs MRK

📍 ETHOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodETHOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ETHOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ETHOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ETHOF
Annual income on $10K today (after 15% tax)
$135,566.19/yr
After 10yr DRIP, annual income (after tax)
$929,737,410,753,495.90/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, ETHOF beats the other by $929,737,410,745,167.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ETHOF + MRK for your $10,000?

ETHOF: 50%MRK: 50%
100% MRK50/50100% ETHOF
Portfolio after 10yr
$614359756.32M
Annual income
$546,904,359,271,661.40/yr
Blended yield
89.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ETHOF
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ETHOF buys
0
MRK buys
0
No recent congressional trades found for ETHOF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricETHOFMRK
Forward yield1594.90%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$1228719512.57M$56.8K
Annual income after 10y$1,093,808,718,533,524.60$9,798.13
Total dividends collected$1218956337.32M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ETHOF vs MRK ($10,000, DRIP)

YearETHOF PortfolioETHOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$170,190$159,489.63$11,206$366.19+$159.0KETHOF
2$2,718,877$2,536,774.03$12,650$502.35+$2.71METHOF
3$40,784,357$37,875,158.19$14,407$694.19+$40.77METHOF
4$574,615,077$530,975,815.49$16,585$967.82+$574.60METHOF
5$7,606,402,582$6,991,564,449.53$19,342$1,363.89+$7606.38METHOF
6$94,634,224,231$86,495,373,468.44$22,913$1,947.19+$94634.20METHOF
7$1,106,980,779,788$1,005,722,159,860.80$27,662$2,823.89+$1106980.75METHOF
8$12,179,238,092,813$10,994,768,658,440.16$34,159$4,173.35+$12179238.06METHOF
9$126,084,854,243,883$113,053,069,484,572.60$43,337$6,308.80+$126084854.20METHOF
10$1,228,719,512,574,479$1,093,808,718,533,524.60$56,776$9,798.13+$1228719512.52METHOF

ETHOF vs MRK: Complete Analysis 2026

ETHOFStock

Prospector Metals Corp. identifies, explores for, and develops mineral properties in the United States and Canada. The company explores for gold, silver, and copper deposits. It owns a right to acquire a 100% interest in the Perk-Rocky project located in Williams Lake, British Columbia; the Gaffney gold property covering an area of 8,172-hectare located in central British Columbia; the Whitton Lake claim block covering an area of 4,400-hectare located in Ontario; the Fairchild Gold project covering 2,228-hectares located in the northeast of Sioux Lookout, Ontario; the Toogood claim covering 6,675 hectares and McGrath claim covering 1,800-hectares located on New World Island, Newfoundland; and the Deep Cove and Virgin Arm claims located on New World Island, Newfoundland. The company also owns a right to acquire a 100% interest in the Campbell Lake gold project located in the north of the town of Armstrong, Ontario; the Schefferville Gold Project consist of 48 mineral claims covering 2,359 hectares located in Quebec; the Bassano project located in Quebec; and the Pine Pass Project located in northeastern British Columbia. In addition, it entered into an agreement to earn 50% undivided interest in the Iron Point Project located in Nevada; 70% interest in the Savant Lake gold property located in Thunder Bay, Ontario; 70% interest in the Ligneris property located north of Rouyn-Noranda, Quebec; and 100% interest in the 325-hectare Fairbanks claim located on New World Island, Newfoundland, as well as holds interest in the Fuchsite Lake Gold Project that comprises 3750 hectares located in Fuchsite Lake Gold Project. Further, the company holds a 100% interest in the Leopard Lake Property covering an area of 7,383 hectares located to the northeast of Thunder Bay, Ontario. The company was formerly known as Ethos Gold Corp. and changed its name to Prospector Metals Corp. in April 2022. Prospector Metals Corp. was incorporated in 2007 and is based in Vancouver, Canada.

Full ETHOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ETHOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ETHOF vs SCHDETHOF vs JEPIETHOF vs OETHOF vs KOETHOF vs MAINETHOF vs JNJETHOF vs ABBVETHOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.